Assenagon Asset Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $387M | Buy |
|
|||||
|
2025
Q2 | $146M | Buy |
|
|||||
|
2025
Q1 | $40.5M | Sell |
|
|||||
|
2024
Q4 | $54M | Sell |
|
|||||
|
2024
Q3 | $196M | Buy |
|
|||||
|
2024
Q2 | $61.7M | Sell |
|
|||||
|
2024
Q1 | $111M | Buy |
|
|||||
|
2023
Q4 | $25.5M | Sell |
|
|||||
|
2023
Q3 | $47.4M | Buy |
|
|||||
|
2023
Q2 | $25M | Sell |
|
|||||
|
2023
Q1 | $62.3M | Sell |
|
|||||
|
2022
Q4 | $67.2M | Sell |
|
|||||
|
2022
Q3 | $104M | Buy |
|
|||||
|
2022
Q2 | $25.9M | Sell |
|
|||||
|
2022
Q1 | $50.3M | Sell |
|
|||||
|
2021
Q4 | $78.7M | Buy |
|
|||||
|
2021
Q3 | $65.2M | Buy |
|
|||||
|
2021
Q2 | $2.05M | Sell |
|
|||||
|
2021
Q1 | $16.6M | Sell |
|
|||||
|
2020
Q4 | $47.7M | Buy |
|
|||||
|
2020
Q3 | $1.21M | Sell |
|
|||||
|
2020
Q2 | $2.99M | Sell |
|
|||||
|
2020
Q1 | $25.2M | Sell |
|
|||||
|
2019
Q4 | $78.1M | Buy |
|
|||||
|
2019
Q3 | $40.6M | Sell |
|
|||||
|
2019
Q2 | $56.9M | Buy |
|
|||||
|
2019
Q1 | $11.2M | Sell |
|
|||||
|
2018
Q4 | $48.4M | Buy |
|
|||||
|
2018
Q3 | $10.8M | Sell |
|
|||||
|
2018
Q2 | $35.8M | Buy |
|
|||||
|
2018
Q1 | $15.8M | Buy |
|
|||||
|
2017
Q4 | $1.5M | Sell |
|
|||||
|
2017
Q3 | $71.3M | Buy |
|
|||||
|
2017
Q2 | $820K | Buy |
|